news - International Biopharmaceutical Industry

Current Edition

news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the...

1 June 2018 news Astellas | biopharma

Continue Reading →

news

vTv Therapeutics shares soar on licensing tie-up with Chinese group Newsoara Biopharma

Newsoara will develop vTv Therapeutics' HPP737 as a new treatment for chronic obstructive pulmonary disease VTv Therape...

1 June 2018 news chinese | group

Continue Reading →

news

Half of orphan drug sales to come from cancer, Evaluate finds

Oncology already sits as the top-selling therapeutic area on the orphan drug market, but a new report predicts it to account for even more — half, in fact — of sa...

1 June 2018 news cancer | Drug

Continue Reading →

news

TherapeuticsMD garners FDA OK for Imvexxy

TherapeuticsMD got a green light from the Food and Drug Administration for TX-004HR, a treatment for moderate-to-severe dyspareunia, or vaginal pain during sexual...

1 June 2018 news FDA | Imvexxy

Continue Reading →

news

Allergan to sell off women’s health, anti-infective businesses

Allergan plans to sell its women's health and infectious disease units, aiming to shore up investor confidence and more narrowly focus the company amid a steady e...

1 June 2018 news Allergan | anti-effective

Continue Reading →

news

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

The Food and Drug Administration announced Wednesday an “innovation challenge" aimed at encouraging the development of medical devices such as digital hea...

1 June 2018 news challenge | combat

Continue Reading →

news

PhRMA criticizes ICER in latest skirmish over valuing drugs

Industry lobbying group PhRMA on Thursday warned the use of cost-effectiveness estimates like those developed by the Institute for Clinical and Economic Review co...

1 June 2018 news Drugs | ICER

Continue Reading →

news

Vertex, CRISPR gene-editing therapy hit with clinical hold

U.S. regulators have placed a clinical hold on CRISPR Therapeutics' lead candidate, spurring a double-digit drop in the Swiss biotech's stock value by Thursday mo...

1 June 2018 news clinical | CRISPR

Continue Reading →

news

Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing

Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing ...

25 May 2018 news company | discovery

Continue Reading →

news

Mundipharma to launch web-based chat bot for feminine care

BETADINE Utilises AI Technology in First Ever Feminine Healthcare Chat Bot BETADINE, which is produced by multinational healthcare organisation Mundipharma, is the...

25 May 2018 news bot | care

Continue Reading →